Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 1,345

Document Document Title
WO/2014/069620A1
The present invention is a method for producing a liquid composition with a pH of 10.0 or more comprising tetrahydro-4H-1,3,5-oxadiazine-4-one and water by reacting urea and formaldehyde in water, the molar feed ratio of formaldehyde/ure...  
WO/2014/040709A1
The present invention relates to a compound of formula (1) wherein X1 represents O or NR6, X2 represents O or NR6, X3 represents O or NR1, R1 represents H or C1 to C3 alkyl, R2 represents H, or a linear or branched C1 - C8 alkyl optional...  
WO/2014/028669A1
The present invention relates to aryl sulfones and related compounds that are modulators of ROR-gamma receptors. The invention also provides pharmaceutical compositions comprising these modulators, and methods of modulating ROR-gamma rec...  
WO/2013/187480A1
An aim of the present invention is to provide a novel cyclic depsipeptide derivative and a pest control agent comprising the same. According to the present invention, a compound represented by formula (1) or a stereoisomer thereof, a pes...  
WO/2013/184734A1
The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are Factor VIIa inhibitors which may be used as medicaments.  
WO/2013/172171A1
A cyclic carbodiimide compound represented by formulas (O-1) or (O-2) can be used for producing a polyester film that does not contain isocyanates with a small molecular weight and that has excellent thickness uniformity without any thic...  
WO/2013/115884A3
Provided herein are novel small molecule pyridomyrimidone viral inhibitor agents of Formula (I), such as 4-acetyl-2,3,7,8-tetrahydro-3-phenylpyrido[l,2-f]pyrimidin-1 -one, and methods of using pharmaceutical or therapeutic compositions c...  
WO/2013/139697A1
The conformationally restricted, spatially defined macrocyclic ring system of formula (I) is constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. Macrocycles described by this ring system I ar...  
WO/2013/119184A1
The invention relates to the synthesis of peptides, proteins and related bioconjugates, and in particular, to such synthesis using a peptide ligation method whereby a C-terminal salicylaldehyde ester peptide is reacted with an aminoacyl-...  
WO/2013/116682A1
The invention relates generally to macrocyclic compounds of formula I and their therapeutic use. More particularly, the invention relates to macrocyclic compounds that modulate the activity of IL-17 and/or are useful in the treatment of ...  
WO/2013/104613A1
The invention relates to a compound of formula (I) wherein A, B, D and R1 to R6 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.  
WO/2013/098572A1
Present invention refers to complex-forming compounds of the general formula and the use and preparation thereof.  
WO/2013/088162A1
Compounds of general formula (I) wherein X, X', Y, Y', A and A' are as defined herein have anitmicrobial activity.  
WO/2012/142457A3
The present invention relates to a macrolactam compound, and methods for treating a subject with malaria using the macrolactam compound, represented by structural formula (l), wherein the values and preferred values of the variables are ...  
WO/2012/142457A8
The present invention relates to a macrolactam compound, and methods for treating a subject with malaria using the macrolactam compound, represented by structural formula (l), wherein the values and preferred values of the variables are ...  
WO/2012/122383A3
The present invention provides compounds, compositions thereof, and methods of using the same.  
WO/2012/096934A3
Methods for preventing or treating retroviral infection, such as human immunodeficiency virus, in vivo utilize transcriptional inhibitory compounds. These include cortistatin A and analogs of the cortistatin family.  
WO/2012/142457A2
The present invention relates to a macrolactam compound, and methods for treating a subject with malaria using the macrolactam compound, represented by the following structural formula (l), wherein the values and preferred values of the ...  
WO/2012/069859A1
The invention relates to fluorescent dyes of formula (I) which at a sensitive to sodium ions and optionally also to potassium ions, and to.' salts, of those compounds which are capable to salt formation - in this formula Rx is a group of...  
WO/2011/085793A3
The invention relates to polyoxaziridines, to the use thereof for cross-linking unsaturated polymers, and to a hardenable composition comprising (a) a polyoxaziridine, (b) an unsaturated polymer or a mixture of polymers, at least one pol...  
WO/2011/149250A3
The present invention relates to a tricarbonyl technetium-99m or rhenium-188 label ring RGD derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagn...  
WO/2011/155624A1
Disclosed is a cyclic carbodiimide compound represented by formula (i), the compound being useful as a terminal-blocking agent for polymers. (In formula (i), X is a specific di- or tetravalent group; q is 0 when X is the divalent group, ...  
WO/2011/149250A2
The present invention relates to a tricarbonyl technetium-99m or rhenium-188 label ring RGD derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagn...  
WO/2011/069045A3
The disclosure relates generally to methods for the preparation of a family of natural compounds, the syrbactins and their analogs.  
WO/2011/129501A1
The present invention relates to a method for preparing a poly(ether sulfonimide or -amide)copolymer using cyclic oligomers, and more particularly, to a method for preparing a poly(ether sulfonimide or -amide)copolymer by preparing cycli...  
WO/2011/087155A1
Provided is a resin composition which comprises polylactic acid, releases no isocyanate group-containing compound in the production process thereof, is highly resistant to hydrolysis and has a low environmental burden. The resin composit...  
WO/2011/069995A1
The present invention relates firstly to the discovery of the previously unknown 24- membered cyclooctadepsipeptides PF1022-V, PF1022-W, XRB-C894, XRB-C942, XRB-C976, XRB-C1010, XRB-C1044, XRB-E922, XRB-E956, XRB-E990, XRB-E1024, XRB-S95...  
WO/2011/069045A2
The disclosure relates generally to methods for the preparation of a family of natural compounds, the syrbactins and their analogs.  
WO/2010/108058A3
Compounds that stimulate fibroblast growth factor production, and thus cell growth are provided. Also provided are compositions comprising the compounds and methods of using the compounds. The compounds can be used to treat wounds, to ex...  
WO/2010/043218A3
The invention relates to a ligand of formula (I), where (CH-R1) and (CH-R1') are substituted or non-substituted methylene bridges; the individual R1 and R1', and R3 and R3', are each selected independently of each other from hydrogen, su...  
WO/2011/001052A1
The invention relates to a targeting agent, to which at least one cryptophycin is attached, of the formula (I), where: R1 is a halogen atom and R2 is an OH group, an acyl group derived from an amino acid AA or a (C1-C4)alkanoyloxy group;...  
WO/2010/146404A1
The invention relates to adamantane diaza-crown ether derivatives and the use of mono and diaza-crown ether adamantine derivatives in treatment, especially in tumor treatment. Adamantane aza-crown ethers were obtained by reaction of the ...  
WO/2009/127338A8
The present invention relates to novel carboxylic acid derivates of the formula (I), having an oxo-substituted azaheterocyclic partial structure, method for the production thereof, use thereof for treating and/or preventing illnesses and...  
WO/2010/119906A1
Disclosed is a novel herbicide. A haloalkylsulfonanilide derivative represented by formula (1) or an agrochemically acceptable salt thereof. In formula (1), Z represents –C(R9)(R10)- or –N(R11)-; A represents an oxygen atom, a sulfur...  
WO/2010/108058A2
Compounds that stimulate fibroblast growth factor production, and thus cell growth are provided. Also provided are compositions comprising the compounds and methods of using the compounds. The compounds can be used to treat wounds, to ex...  
WO/2010/108067A1
Disclosed are compounds, pharmaceutical compositions containing the compounds, methods for using the compounds and processes for making the compounds. More specifically, the disclosure relates to alpha-(N-benzenesulfonamido)cycloalkyl co...  
WO/2010/102717A1
The present application relates to novel alkyl carboxylic acids, having an oxo-substituted aza-heterocyclical partial structure, to a method for producing same, to the use thereof for treating and/or preventing disease, and to the use th...  
WO/2010/021693A3
The invention provides novel heterocyclic compounds, pharmaceutical compositions and methods of treatment that modulate levels of MIF expression and treat disorders associated with high or low levels of MIF expression.  
WO/2010/071212A1
Provided is a method for capping the end of a polymer by means of a carbodimide composition without freeing an isocyanate compound. This method uses as the polymer end-capping agent a compound which has one carbodimide group and which co...  
WO/2010/071213A1
Provided is a resin composition which contains polyester and has no odor caused by a free isocyanate compound. This resin composition contains a terminal-modified polyester (component A) and a compound (component B) which has one carbodi...  
WO/2010/071211A1
Provided are cyclic carbodiimide compounds that are useful as end-sealing agents for polymer compounds. The cyclic carbodiimide compounds are represented by formula (i). (in the formula, X is a 2-valent group, or a 4-valent group represe...  
WO/2010/043218A2
The invention relates to a ligand of formula (I), where (CH-R1) and (CH-R1’) are substituted or non-substituted methylene bridges; the individual R1 and R1’, and R3 and R3’, are each selected independently of each other from hydrog...  
WO/2010/022249A3
The invention provides macrocyclic compounds of formula (I) and methods for their synthesis and use. In particular, the invention provides macrocyclic compounds that modulate the activity of tumor necrosis factor alpha and/or are useful ...  
WO/2010/021693A2
The invention provides novel heterocyclic compounds, pharmaceutical compositions and methods of treatment that modulate levels of MIF expression and treat disorders associated with high or low levels of MIF expression.  
WO/2010/022249A2
The invention provides macrocyclic compounds and methods for their synthesis and use. In particular, the invention provides macrocyclic compounds that modulate the activity of tumor necrosis factor alpha and/or are useful in the treatmen...  
WO/2009/146802A1
The invention relates to compounds of the formula (I) which are inhibitors of activated thrombin-activable fibrinolysis inhibitor. The compounds of the formula I are suitable for producing medicaments for prophylaxis, secondary preventio...  
WO/2009/127338A1
The present invention relates to novel carboxylic acid derivates of the formula (I), having an oxo-substituted azaheterocyclic partial structure, method for the production thereof, use thereof for treating and/or preventing illnesses and...  
WO/2009/092293A1
A compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof, which can inhibit HIV replication.  
WO/2009/037642A1
Disclosed are heterocyclic scaffolds useful, for example, for solid-phase organic synthesis of combinatorial libraries and methods for the preparation thereof. Also disclosed are libraries, including combinatorial libraries, and methods ...  
WO/2008/138527A3
The present invention relates to novel halogenated aromatic oxime compounds and compositions comprising said compounds, and to the use of the novel compounds and compositions as anti-fouling agents.  

Matches 51 - 100 out of 1,345